Feb. 13 - Feike Sijbesma, Chairman of the DSM Managing Board, commented: 'DSM performed well in 2007 with good sales growth, particularly during the fourth quarter, and strong results in light of the challenges faced by the company during the year. In 2008, we also expect to perform well.' 'DSM is fully on track to meet the objectives set out in the accelerated Vision 2010 strategy. In 2008, we will continue the transition towards a Life Sciences and Materials Sciences company, addressing the needs of tomorrow's society and capable of delivering sustainable growth.'
• Strong Q4 results based on 10% organic sales growth.
• Operating profit for 2007 of EUR 823 million in line with expectations.
• Net profit before exceptional items at EUR 558 million, better than last year; EPS 8% higher.
• Proposed dividend EUR 1.20 per ordinary share (+20%).
• Outlook: Operating profit before exceptional items in 2008 expected to approach level achieved in 2007.